Autophagy in kidney disease and aging: lessons from rodent models

Slides:



Advertisements
Similar presentations
Autophagy Part 1 Dr Aliwaini.
Advertisements

The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease  Konrad Talbot, Hoau-Yan Wang 
Volume 76, Issue 9, Pages (November 2009)
Interactions between Autophagy Receptors and Ubiquitin-like Proteins Form the Molecular Basis for Selective Autophagy  Vladimir Rogov, Volker Dötsch,
Sustaining Proliferative Signaling and Evading Growth Suppressors
AMPK-Dependent Phosphorylation of ULK1 Induces Autophagy
Figure 1 mTOR pathway activation
Autophagy Receptors and Neurodegenerative Diseases
Figure 1 The machinery of autophagy
Innate and Adaptive Immunity through Autophagy
Volume 140, Issue 7, Pages (June 2011)
Overgrowth Syndromes Caused by Somatic Variants in the Phosphatidylinositol 3- Kinase/AKT/Mammalian Target of Rapamycin Pathway  Gozde Akgumus, Fengqi.
Methods in Mammalian Autophagy Research
Personalizing Therapy for Colorectal Cancer
Targeting ROS1 with Anaplastic Lymphoma Kinase Inhibitors: A Promising Therapeutic Strategy for a Newly Defined Molecular Subset of Non–Small-Cell Lung.
Harold A. Franch, MD  Journal of Renal Nutrition 
Personalizing Therapy for Colorectal Cancer
Figure 3 Physiological regulation of autophagy in the heart
Figure 1 mTOR complex biology
The pathway signalling starts with the binding of insulin or growth factors to insulin receptors. The pathway signalling starts with the binding of insulin.
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer  Vassiliki Papadimitrakopoulou,
Jing Zhang, Thomas M. Roberts, Ramesh A. Shivdasani  Gastroenterology 
Maria M. Mihaylova, David M. Sabatini, Ömer H. Yilmaz  Cell Stem Cell 
Identification of TOR Signaling Complexes
Figure 1 The insulin signalling pathway
Inhibition of mammalian target of rapamycin: Two goals with one shot?
Rapamycin: One Drug, Many Effects
Autophagosome formation and Ubiquitin-like conjugation pathway
FGFR Signaling as a Target for Lung Cancer Therapy
mTORC1 signalling links cellular growth with autophagy
Volume 76, Issue 9, Pages (November 2009)
An Emerging Role of mTOR in Lipid Biosynthesis
Douglas R. Green, Beth Levine  Cell 
Metabolic Control of Autophagy
mTORC1 Signaling: A Double-Edged Sword in Diabetic β Cells
Amino acid-dependent regulation of autophagy by mTORC1
Anna S. Gukovskaya, Ilya Gukovsky, Hana Algül, Aida Habtezion 
Volume 139, Issue 2, Pages e3 (August 2010)
Volume 74, Issue 5, Pages (September 2008)
Delayed kidney graft function: from mechanism to translation
AKT/PKB Signaling: Navigating the Network
Volume 93, Issue 5, Pages (March 2017)
Pierre Theurey, Jennifer Rieusset  Trends in Endocrinology & Metabolism 
AKT/PKB Signaling: Navigating Downstream
Nucleophagy: A New Look at Past Observations
Autophagy protects proximal tubular cells from injury and apoptosis
Tumor Metabolism: MAGE-A Proteins Help TRIM Turn Over AMPK
Rapamycin: One Drug, Many Effects
A TRIM16-Galectin3 Complex Mediates Autophagy of Damaged Endomembranes
Autophagy, Immunity, and Microbial Adaptations
The Process of Autophagy
Figure 2 Autophagosome formation in mammalian cells
Autophagy in liver diseases: Time for translation?
mTOR and Akt Signaling in Cancer: SGK Cycles In
What’s Eating the Epidermis
Alex Kentsis, A. Thomas Look  Cell Stem Cell 
Simon Ekman, MD, PhD, Murry W. Wynes, PhD, Fred R. Hirsch, MD, PhD 
The Cytoskeleton–Autophagy Connection
Brian K. Kennedy, Dudley W. Lamming  Cell Metabolism 
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease  Konrad Talbot, Hoau-Yan Wang 
Tobias B. Huber, Gerd Walz, E Wolfgang Kuehn  Kidney International 
Volume 104, Issue 4, Pages (February 2001)
Autophagy in the Cellular Energetic Balance
Dysregulation of the mTOR Pathway Secondary to Mutations or a Hostile Microenvironment Contributes to Cancer and Poor Wound Healing  Richard A.F. Clark,
Mitochondrial Dynamics: A Strategy for Avoiding Autophagy
Autophagy and the Integrated Stress Response
Autophagy: Renovation of Cells and Tissues
Nutrient Sensing, Metabolism, and Cell Growth Control
Successful targeting of ErbB2 receptors—is PTEN the key?
Il Nobel per la medicina 2016 alle scoperte sulla "pulizia cellulare"
Presentation transcript:

Autophagy in kidney disease and aging: lessons from rodent models Olivia Lenoir, Pierre-Louis Tharaux, Tobias B. Huber  Kidney International  Volume 90, Issue 5, Pages 950-964 (November 2016) DOI: 10.1016/j.kint.2016.04.014 Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 1 Autophagy pathway. The autophagic pathway responds to signals from the environment. Nutrients status controls autophagy through the mTOR signaling pathway. The class I PI3K-AKT can also activate the mTORC1 complex in response to insulin and other growth factors, acting as a negative regulator of autophagy. Activation of AMPK in response to low energy status (i) inhibits the mTORC1 complex and (ii) activates the ULK1 complex through ULK1 and ATG13 phosphorylation, thereby acting as a positive regulator of autophagy in response to energy depletion. The BECN1/class III PI3K complex, which is inactivated by Bcl2, and the class I PI3K-AKT complex also regulate autophagy. Upon activation, the Beclin1-VPS34-ATG14L-P150 complex will generate PI3P, which promotes autophagosomal membrane nucleation in coordination with the ULK1-ATG13-ATG101-FIP200 complex. The ATG5-ATG12-ATG16L complex and the LC3-phosphatidylethanolamine system will play roles in cargo recruitment, membrane elongation, and autophagosome maturation. Lysosome fusion to autophagosome to form autolysosome is mediated through SNARE proteins, and lysosomal hydrolases degrade proteins, lipids, and nucleic acids. AKT, protein kinase B; AMPK, adenosine monophosphate–activated protein kinase; ATG, autophagy-related gene; BCL2, B-cell lymphoma 2; BCLXL, B-cell lymphoma–extra large; DEPTOR, DEP domain-containing mTOR-interacting protein; FIP200, FAK family kinase-interacting protein of 200 kDa; LC3, microtubule-associated protein 1 light chain 3; MLST8, target of rapamycin complex subunit LST8; mTOR, mammalian target of rapamycin; mTORC1, mTOR complex 1; PI3K, phosphatidylinositol-3-kinase; PI3P, phosphatidylinositol-3-phosphate; PRAS40, proline-rich v-akt murine thymoma viral oncogene homolog 1 substrate 40 kDa; Raptor, regulatory-associated protein of mTOR; SNARE, soluble NSF attachment protein receptor; ULK1, Unc51-like kinase 1. Kidney International 2016 90, 950-964DOI: (10.1016/j.kint.2016.04.014) Copyright © 2016 International Society of Nephrology Terms and Conditions